Login / Signup

Mechanism of Zhinao Capsule in Treating Alzheimer's Disease Based on Network Pharmacology Analysis and Molecular Docking Validation.

Yanzhen MaShao-Peng HuangHui JiangWenming Yang
Published in: Journal of healthcare engineering (2022)
to affect T cell receptor (TCR), TNF, and MAPK signaling pathway, thereby achieving the treatment of AD. This study provides a scientific basis for further exploring the potential mechanism of ZNC in the treatment of AD and a reference for its clinical application.
Keyphrases
  • molecular docking
  • signaling pathway
  • pi k akt
  • rheumatoid arthritis
  • epithelial mesenchymal transition
  • regulatory t cells
  • cognitive decline
  • endoplasmic reticulum stress